Synthesis of CaCO3 supported nano zero-valent iron-nickel nanocomposite (nZVI-Ni@CaCO3) and its application for trichloroethylene removal in persulfate activated system.

Nano zero-valent (nZVI) based composite have been widely utilized in environmental remediation. However, the rapid agglomeration and quick deactivation of nZVI limited its application on large scale. In this work, CaCO3 supported nZVI-Ni catalyst, namely nZVI-Ni@CaCO3 was prepared and used for the efficient removal of trichloroethylene (TCE) in PS oxidation process. The successful disbursement of nZVI-Ni on CaCO3 support material not only increased the surface area of nZVI-Ni@CaCO3 (69.45 m2/g) with respect to CaCO3 (5.92 m2/g) and bare nZVI (13.29 m2/g) but also improved the catalytic activity. XRD, XPS and FTIR analysis confirmed the successful formation of nZVI-Ni@CaCO3 nanoparticles. The nZVI-Ni@CaCO3 nanoparticles combined with PS had achieved complete removal of TCE (99.8%) with dosage of 36 mg/L and 1.34 mM respectively. These results showed that the use of CaCO3 as support material for nZVI-Ni could have significant influence on contaminant removal process. Scavenging and EPR tests validated the existence of SO4•-, OH• and O2•- radicals in PS/nZVI-Ni@CaCO3 system and highlighted the dominant role of SO4•- radicals in TCE removal process. HCO3- ions and humic acid have shown adverse effect on TCE removal due to radical scavenging and buffering effect. Owing to improved catalytic activity and easy preparation, the nZVI-Ni@CaCO3 nanoparticles could be served as an alternative strategy for environmental remediation.

Musculoskeletal discomfort and wrist flexor tendonitis among street sweepers and associated risk factors.

BACKGROUND: Street sweepers are reported to suffer from high rates of work-related musculoskeletal discomfort worldwide, especially in their wrists. OBJECTIVE: The study aimed to 1) determine the prevalence of musculoskeletal disorders and 2) specifically determine the prevalence of wrist flexor tendonitis and its associated risk factors among street sweepers. METHODS: Three hundred and eighty-five sweepers employed by the Faisalabad Waste Management Company (FWMC) participated in this cross-sectional study. A self-structured questionnaire was used to collect data: the first section provided demographic information, the second assessed musculoskeletal disorders, and the third section assessed the wrist flexor tendonitis among street sweepers. RESULTS: The mean age of the sweepers was 38.34 years. Out of 385 street sweepers, the prevalence of musculoskeletal discomfort was reported in 265 (68.83%). The prevalence of musculoskeletal discomfort in sweepers reported during COVID-19 according to the past 12 months, the highest three prevalence rates were 46.5% in the wrists/hands, 37.9% in the shoulders and 35.1% in the lower back. The three highest prevalence rates of musculoskeletal discomfort in sweepers according to the last 7 days were 29.6% in the wrists/hands, 24.4% in the lower back and 24.2% in the shoulders. Out of total 385 participants, prevalence of wrist flexor tendonitis was reported in 103 (26.8%) sweepers. Significant association was found (p < 0.05) between wrist flexor tendonitis and gender (p < 0.003), age (p < 0.05), working experience (p < 0.003), street sweeping distance (p < 0.01), number of brooms used per month (p < 0.002) and getting tired at the end of work (p < 0.001). CONCLUSION: The prevalence of musculoskeletal discomfort and wrist flexor tendonitis seen during COVID-19 is high among sweepers, with wrist/hand being the most commonly reported region for pain. This study emphasizes the importance of providing guidelines about effective precautionary healthcare measures for street sweepers.

In situ Forming Hyperbranched PEG-Thiolated Hyaluronic Acid Hydrogels With Honey-Mimetic Antibacterial Properties.

The rapidly increasing resistance of bacteria to currently approved antibiotic drugs makes surgical interventions and the treatment of bacterial infections increasingly difficult. In recent years, complementary strategies to classical antibiotic therapy have, therefore, gained importance. One of these strategies is the use of medicinal honey in the treatment of bacterially colonized wounds. One of the several bactericidal effects of honey is based on the in situ generation of hydrogen peroxide through the activity of the enzyme glucose oxidase. The strategy underlying this work is to mimic this antibacterial redox effect of honey in an injectable, biocompatible, and rapidly forming hydrogel. The hydrogel was obtained by thiol-ene click reaction between hyperbranched polyethylene glycol diacrylate (HB PEGDA), synthesized using reversible addition-fragmentation chain transfer (RAFT) polymerization, and thiolated hyaluronic acid (HA-SH). After mixing 500 µL HB PEGDA (10%, w/w) and 500 µL HA-SH (1%, w/w) solutions, hydrogels formed in ∼60 s (HB PEGDA/HA-SH 10.0-1.0), as assessed by the tube inverting test. The HB PEGDA/HA-SH 10.0-1.0 hydrogel (200 µL) was resistant to in vitro dissolution in water for at least 64 days, absorbing up to 130 wt% of water. Varying glucose oxidase (GO) amounts (0-500 U/L) and constant glucose content (2.5 wt%) were loaded into HB PEGDA and HA-SH solutions, respectively, before hydrogel formation. Then, the release of H2O2 was evaluated through a colorimetric pertitanic acid assay. The GO content of 250 U/L was selected, allowing the formation of 10.8 ± 1.4 mmol H2O2/L hydrogel in 24 h, under static conditions. The cytocompatibility of HB PEGDA/HA-SH 10.0-1.0 hydrogels loaded with different GO activities (≤ 500 U/L) at a constant glucose amount (2.5 wt%) was investigated by in vitro assays at 24 h with L929 and HaCaT cell lines, according to DIN EN ISO 10993-5. The tests showed cytocompatibility for GO enzyme activity up to 250 U/L for both cell lines. The antibacterial activity of HB PEGDA/HA-SH 10.0-1.0 hydrogels loaded with increasing amounts of GO was demonstrated against various gram-positive bacteria (S. aureus and S. epidermidis), antibiotic-resistant gram-positive bacteria (MRSA and MRSE), gram-negative bacteria (P. aeruginosa, E. coli, and A. baumanii), and antibiotic-resistant gram-negative strains (P. aeruginosa and E. coli) using agar diffusion tests. For all gram-positive bacterial strains, increasing efficacy was measured with increasing GO activity. For the two P. aeruginosa strains, efficacy was shown only from an enzyme activity of 125 U/L and for E. coli and A. baumanii, efficacy was shown only from 250 U/L enzyme activity. HB PEGDA/HA-SH 10.0-1.0 hydrogels loaded with ≤250 U/L GO and 2.5 wt% glucose are promising formulations due to their fast-forming properties, cytocompatibility, and ability to produce antibacterial H2O2, warranting future investigations for bacterial infection treatment, such as wound care.

Enhancement in reactivity via sulfidation of FeNi@BC for efficient removal of trichloroethylene: Insight mechanism and the role of reactive oxygen species.

A novel catalyst of sulfidated iron-nickel supported on biochar (S-FeNi@BC) was synthesized to activate persulfate (PS) for the removal of trichloroethylene (TCE). A number of techniques including XRD, SEM, TEM, FTIR, BET and EDS were employed to characterize S-FeNi@BC. The influence of sulfur to iron ratio (S/F) on TCE removal was investigated by batch experiments and a higher TCE removal (98.4%) was achieved at 0.22/1 ratio of S/F in the PS/S-FeNi@BC oxidation system. A dominant role in iron species conversion was noticed by the addition of sulfur in FeNi@BC system. Significant enhancement in recycling of the dissolved and surface Fe(II) was confirmed which contributed to the generation of free and surface-bound active radical species (OH, O2-, 1O2, SO4-). Further, the presence and contribution of these radicals were validated by the electron paramagnetic resonance (EPR) and quenching study. In addition, XPS results demonstrated the dominant role of S(-II) with the increase of Fe(II) from 36.3% to 58.6% and decrease of Fe(III) from 52.1% to 39.8% in the PS/S-FeNi@BC system. In crux, the influence of initial pH, catalyst dosage, oxidant dosage, and inorganic ions (HCO3-, Cl-, NO3- and SO42-) on TCE removal was also investigated. The findings obtained from this study suggest that S-FeNi@BC is an appropriate catalyst to activate PS for TCE contaminated groundwater remediation.

Validation of in vitro assays in three-dimensional human dermal constructs.

Three-dimensional cell culture systems are urgently needed for cytocompatibility testing of biomaterials. This work aimed at the development of three-dimensional in vitro dermal skin models and their optimization for cytocompatibility evaluation. Initially "murine in vitro dermal construct" based on L929 cells was generated, leading to the development of "human in vitro dermal construct" consisting of normal human dermal fibroblasts in rat tail tendon collagen type I. To assess the viability of the cells, different assays CellTiter-Blue®, RealTime-Glo™ MT, and CellTiter-Glo® (Promega) were evaluated to optimize the best-suited assay to the respective cell type and three-dimensional system. Z-stack imaging (Live/Dead and Phalloidin/DAPI-Promokine) was performed to visualize normal human dermal fibroblasts inside matrix revealing filopodia-like morphology and a uniform distribution of normal human dermal fibroblasts in matrix. CellTiter-Glo was found to be the optimal cell viability assay among those analyzed. CellTiter-Blue reagent affected the cell morphology of normal human dermal fibroblasts (unlike L929), suggesting an interference with cell biological activity, resulting in less reliable viability data. On the other hand, RealTime-Glo provided a linear signal only with a very low cell density, which made this assay unsuitable for this system. CellTiter-Glo adapted to three-dimensional dermal construct by optimizing the "shaking time" to enhance the reagent penetration and maximum adenosine triphosphate release, indicating 2.4 times higher viability value by shaking for 60 min than for 5 min. In addition, viability results showed that cells were viable inside the matrix. This model would be further advanced with more layers of skin to make a full thickness model.

Memory-enhancing effect of aspirin is mediated through opioid system modulation in an AlCl3-induced neurotoxicity mouse model.

Neurodegenerative disorders such as Alzheimers disease (AD) are multifaceted and there are currently a limited number of therapeutic strategies available to treat them. Aspirin is known to act on multiple therapeutic targets and is a successful anti-inflammatory agent in various tissues. The present study aimed to ascertain the performance of aspirin when employed as a therapeutic agent to treat neurodegeneration on novel targets, including opioid system genes, in an AlCl3-induced neurotoxicity mouse model. The effects of two doses of aspirin (5 and 20 mg/kg aspirin for 12 days) were investigated in an AlCl3-induced neurotoxicity mouse model (150 mg/kg AlCl3 for 12 days). Neurological improvements were assessed through different behavioral tests and the effects of aspirin on opioid system gene expression levels were assessed by reverse transcription-polymerase chain reaction. Both doses resulted in improvements in cognitive behavior. A 5 mg/kg dose of aspirin was revealed to be effective for spatial memory improvement (7.14±0.84 sec), whilst a 20 mg/kg dose was superior for improving extinction learning (7.63±4.04%). Aspirin (5 mg/kg) also significantly improved contextual memory (48.05±10.6%) when compared with the AlCl3-treated group (1.49±0.62%; P<0.001). Aspirin was also observed to significantly decrease δ-opioid receptor expression in the cortex (1.09±0.08 and 1.27±0.08, respectively) at both doses (5 and 20 mg/kg) when compared with the AlCl3-treated group (3.69±1.43; P<0.05). Furthermore, aspirin at 5 mg/kg significantly reduced expression of prodynorphin in the cortex (0.57±0.20) when compared with the AlCl3-treated group (1.95±0.84; P<0.05). Notably, the effect of aspirin was significant in the cortex but not in the hippocampus. In summary, aspirin was effective in ameliorating the AD-like symptoms via the modulation of opioid systems. However, additional studies are required to determine the long term effects of aspirin on such conditions.